Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS

NCT01255709 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Arm T1: Primatene Mist HFA
DRUG: Arm T2: Primatene Mist HFA
DRUG: Arm C: Primatene Mist (epinephrine inhalation aerosol, USP)

Sponsor

Amphastar Pharmaceuticals, Inc.